Albany Med and NYOH to Host Translational Oncology Research Symposium
ALBANY, N.Y., August 30, 2012—The sixth annual Translational Oncology Research Symposium, “Transforming Patient Care through Translational Oncology” will be held at the Hilton Garden Inn at Albany Medical Center on October 4 and 5.
This interactive conference focuses on bringing the benefits of basic cancer research to patient care, or “moving from the bench to bedside.” The symposium is hosted by Albany Medical College and New York Oncology-Hematology, PC (NYOH) and is jointly sponsored by KnowledgeOncology and the Postgraduate Institute for Medicine. Attendees can earn up to 5.75 AMA PRA Category 1 Credit(s)TM.
Vincent Verdile, M.D., dean of Albany Medical College, executive vice president for health affairs at Albany Medical Center, and symposium moderator, said, “We are proud to offer this opportunity to bring together leading physicians and researchers to discuss and collaborate on applying innovative oncology research findings to patient care initiatives which we all hope will lead to better outcomes for our patients.”
The symposium is directed by Paul Higgins, Ph.D., and Paula McKeown-Longo, Ph.D., co-directors of Albany Med’s Center for Cell Biology and Cancer Research, and Karen Tedesco, M.D., director of the NYOH Hereditary Cancer Risk Assessment Program.
Lawrence Garbo, M.D., research chairman, Clinical Trials Program, NYOH, will make opening and closing remarks at the conference on Friday. “The physicians and staff of New York Oncology Hematology have played a pivotal role in the FDA approval process of new anti-cancer drugs. To date, nearly 3,000 patients have been enrolled in NYOH research efforts and together, we’re helping to bring the breakthroughs home as they happen,” said Dr. Garbo.
The diverse group of oncology experts includes keynote speakers Jeffrey S. Ross, M.D., chairman, Albany Med Department of Pathology and Laboratory Medicine, and Robert Soiffer, M.D., co-director of the Dana-Farber Cancer Institute Bone Marrow Transplant Program and chief of the Division of Hematologic Malignancies.
Other speakers include:
• Lucy Langer, M.D., national medical director of US Oncology Cancer Genetics;
• Valerie Brutus, M.D., breast surgeon at Albany Medical Center and assistant professor of surgery at Albany Medical College;
• Richard Agag, M.D., reconstructive plastic surgeon at Albany Medical Center and assistant professor of surgery at Albany Medical College;
• David Schenkein, M.D., chief executive officer of Agios and adjunct attending physician in hematology at Tufts Medical Center;
• Ira L. Zackon, M.D., director of the NYOH Stem Cell Transplant Program at Albany Med;
• Martin C. Mihm, Jr., M.D., associate director of the Dana-Farber Cancer Institute’s Melanoma Center and clinical professor of dermatology and pathology at Harvard Medical School; and
• Gary K. Schwartz, M.D., chief of Memorial Sloan-Kettering’s Melanoma and Sarcoma Service and professor of medicine at Weill Cornell Medical College.
To register, go to http://knowonc.com
Albany Medical Center, northeastern New York’s only academic health sciences center, is one of the largest private employers in the Capital Region. It incorporates the 651-bed Albany Medical Center Hospital, which offers the widest range of medical and surgical services in the region, and the Albany Medical College, which trains the next generation of doctors, scientists and other healthcare professionals, and also includes a biomedical research enterprise and the region’s largest physicians practice with 350 doctors. Albany Medical Center works with dozens of community partners to improve the region’s health and quality of life. For more information: www.amc.edu or www.facebook.com/albanymedicalcenter.
Statistical information presented in press releases may no longer be valid.